Horan Securities’s AdaptHealth AHCO Stock Holding History

Horan Securities’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-290	Closed	-$5K	–	307
2020 Q1	$5K	Buy	+290	New	+$4.1K	0.01%	166

Other funds holding AHCO

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Horan Securities's AHCO Position: Q2 2020 in Review

Horan Securities sold out of AdaptHealth (AHCO) in Q2 2020, closing a stake of 290 shares — an estimated $5K sold.

Horan Securities first reported a position in AHCO in Q1 2020 and held it in 1 quarter. The position peaked at $5K in Q1 2020. 53 funds tracked by Wall St. Rank hold AHCO as of Q2 2020.

Horan Securities reported no remaining AdaptHealth position as of Q2 2020 after selling out during the quarter.
Horan Securities sold 290 AdaptHealth shares in Q2 2020, an estimated $5K.
Horan Securities first reported a position in AdaptHealth in Q1 2020 and held it in 1 quarter.
Horan Securities's AdaptHealth position peaked at $5K in Q1 2020.
53 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2020.

Based on Horan Securities's 13F filing for Q2 2020, filed 11 Aug 2020.